Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man.
D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D002854:Chromatography, Paper; D003561:Cytarabine / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D004247:DNA / Q000378:metabolism; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy; D007962:Leukocytes / Q000378:metabolism*; D008113:Liver Neoplasms; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008875:Middle Aged; D009705:Nucleosides / Q000378:metabolism*; D012313:RNA / Q000378:metabolism; D012343:RNA, Transfer / Q000378:metabolism; D014316:Tritium; D014500:Uracil Nucleotides / Q000378:metabolism*; D014529:Uridine / Q000378:metabolism
D009705:Nucleosides; D014500:Uracil Nucleotides; D003561:Cytarabine; D014316:Tritium; D012313:RNA; D004247:DNA; D012343:RNA, Transfer; D014529:Uridine